For immunodeficient patients receiving allogeneic HSC transplants such as those with severe combined immunodeficiencies (ClinicalTrials.gov: NCT02963064), CD117-ADC conditioning alone might be sufficient. Here, KIT is linked to immunodeficiency disease.